Published On 4 Nov, 2021
WHO Approves Bharat Biotech’s Covid Vaccine For Emergency Use

INDIA FURTHERS ITS STATUS AS THE GLOBAL PHARMA HUB

* Bharat Biotech’s Covid vaccine Covaxin gets WHO approval for emergency use

* COVAXIN demonstrated 77.8% effectiveness against symptomatic Covid-19 and 65.2% protection against the new Delta variant

* India was one of the first founders of a COVID vaccine globally.

Bharat Biotech's Covid vaccine Covaxin gets WHO approval for emergency use - Dharmapuri Arvind

Related Posts